Survival after primary enucleation of largest uveal melanomas [4]

Acta Ophthalmologica Scandinavica

Volumn 83, Issue 3, 2005, Pages 398-

  Gambrelle, Joel ^a   Kodjikian, Laurent ^a   Grange, Jean Daniel ^a  

^a CROIX ROUSSE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RUTHENIUM;

BEAM THERAPY; BRACHYTHERAPY; CANCER MORTALITY; CANCER SIZE; CANCER SURVIVAL; CONSERVATIVE TREATMENT; ENUCLEATION; HUMAN; LETTER; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; UVEA MELANOMA;

EID: 21044443355     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2005.0433c.x     Document Type: Letter

References (4)

1. De Potter P (2002): Mélanome choroïdien: approches thérapeutiques actuelles. J Fr Ophtalmol 25: 203-211.
2. Isager P, Ehlers N & Overgaard J (2004): Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas. Acta Ophthalmol Scand 82: 517-525.
3. Kodjikian L, Roy P, Rouberol F et al. (2004): Survival after proton-beam irradiation of uveal melanomas. Am J Ophthalmol 137: 1002-1010.
4. Rouberol F, Roy P, Kodjikian L, Gérard JP, Jean-Louis B & Grange JD (2004): Survival, anatomic and functional longterm results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays). Am J Ophthalmol 137: 893-900.